# Adaptimmune Therapeutics PLC: Form 8-K, filed Jun 16, 2016

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 8-K
- Filed: 2016-06-16
- Accepted by EDGAR: Jun 16, 2016, 06:50 ET
- Period: 2016-06-16
- Accession: 0001104659-16-127557
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000110465916127557/a16-13433_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000110465916127557/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000110465916127557/a16-13433_18k.htm

Filed Jun 16, 2016.
Source: SEC EDGAR, the filing index for accession 0001104659-16-127557. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.
